Physician profile
Margaret Sutter
NPI 1124407986
$4,309.56
in general payments reported to CMS, 2019-2025
39 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $691 · 2023: $981 · 2024: $999 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,365 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,365.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $400.57 | 2022-2025 | Jelmyto |
| Abbvie INC. | $304.02 | 2023-2024 | |
| Teleflex LLC | $285.29 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $212.38 | 2022-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $210.90 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $210.35 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $196.86 | 2025 | |
| Boston Scientific Corporation | $180.64 | 2022-2025 | Axonics |
| Dendreon Pharmaceuticals LLC | $176.45 | 2024-2025 | Provenge |
| Janssen Biotech, INC. | $169.43 | 2022-2024 | Erleada |
| Calyxo, INC. | $161.12 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $156.99 | 2022-2025 | |
| Medtronic, INC. | $156.29 | 2025 | Interstim, Altaviva |
| Procept Biorobotics Corporation | $140.04 | 2022-2024 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $123.76 | 2022-2025 | Lynparza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $115.73 | 2021 | |
| Immunitybio, INC. | $113.90 | 2025 | |
| Ferring Pharmaceuticals INC. | $94.95 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $86.24 | 2023-2025 | |
| Antares Pharma, INC. | $85.26 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $78.84 | 2022-2023 | Xiaflex, Aveed, Edex |
| Axonics, INC. | $78.62 | 2022-2024 | Axonics |
| Verity Pharmaceuticals INC. | $71.83 | 2024-2025 | Trelstar, Tlando |
| Sun Pharmaceutical Industries INC. | $62.07 | 2022-2023 | Yonsa |
| Accord Healthcare, INC. | $57.91 | 2023-2025 | |
| Urovant Sciences INC | $48.85 | 2022 | |
| Olympus America INC. | $44.56 | 2025 | Itind System |
| Foundation Medicine, INC. | $38.27 | 2023 | |
| Endo USA, INC. | $31.48 | 2025 | Xiaflex, Aveed |
| Novo Nordisk INC | $30.58 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $30.23 | 2022 | |
| Tolmar, INC. | $25.44 | 2023 | |
| Alnylam Pharmaceuticals INC. | $20.91 | 2022 | |
| Blue Earth Diagnostics | $19.51 | 2022 | |
| Halozyme INC | $19.39 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $19.33 | 2022 | |
| Telix Pharmaceuticals | $18.51 | 2024 | Illuccix |
| Pfizer INC. | $16.13 | 2023 | |
| Baxter Healthcare | $15.93 | 2023 | Tachosil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Sutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.